Cost of production of live attenuated dengue vaccines: a case study of the Instituto Butantan, Sao Paulo, Brazil.
about
Epidemiological Scenario of Dengue in BrazilNeed of cost-effective vaccines in developing countries: What plant biotechnology can offer?Dengue vaccines: recent developments, ongoing challenges and current candidates.Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in Bandung, IndonesiaA single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trialConsumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia®) in Brazil; Implications for Future Pricing Considerations.Assessing the Economics of Dengue: Results from a Systematic Review of the Literature and Expert Survey.Current issues in the economics of vaccination against dengue.An updated methodology to review developing-country vaccine manufacturer viability.The complexity and cost of vaccine manufacturing - An overview.A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.Dengue dynamics and vaccine cost-effectiveness in Brazil.Feasibility and willingness to pay for dengue vaccine in the threat of dengue fever outbreaks in VietnamThe Challenges Imposed by Dengue, Zika, and Chikungunya to Brazil
P2860
Q24289012-71CDDF72-725E-456D-8EBE-634A4143762BQ26769942-95766261-353D-4B0A-98B0-4AAF7360A9B0Q34367194-3A666FDF-34E8-4BD0-8B4B-1F725210A205Q34999848-80A437F6-229D-4612-BCEE-9AB81D9A0586Q36607295-F0997A21-ACBE-4A7D-9F62-9890BC680012Q37619957-477A2E1C-035D-4C15-B522-F91201B5335CQ38517709-A2B0E3E6-2307-4F5C-A8FC-DBE73943077CQ38661075-B850C110-D3FD-412E-8843-80661706ADA6Q39365283-57D940C3-50BF-496B-B1F1-7852EFC18E0BQ39396164-4C82A72A-B232-4859-A0DA-04EC032092EFQ40116968-0249BF7D-E4AE-46B4-96CA-C6C7358ECE4FQ40243587-DC5099DF-7085-4F72-8B43-40F3094B3653Q57069443-F69E2127-C410-422B-B76E-0A625DDBEF2AQ58698393-69D0B4EC-7957-4797-9C00-44687E2801AA
P2860
Cost of production of live attenuated dengue vaccines: a case study of the Instituto Butantan, Sao Paulo, Brazil.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cost of production of live att ...... o Butantan, Sao Paulo, Brazil.
@en
type
label
Cost of production of live att ...... o Butantan, Sao Paulo, Brazil.
@en
prefLabel
Cost of production of live att ...... o Butantan, Sao Paulo, Brazil.
@en
P2093
P1433
P1476
Cost of production of live att ...... o Butantan, Sao Paulo, Brazil.
@en
P2093
D P Francis
N M Frazatti-Gallina
P Whitehead
R T Mahoney
S S Whitehead
P304
P356
10.1016/J.VACCINE.2012.02.064
P407
P577
2012-03-08T00:00:00Z